Heritable Genome Editing with CRISPR/Cas9 in the Silkworm, Bombyx mori

被引:68
|
作者
Wei, Wei [1 ]
Xin, Huhu [2 ]
Roy, Bhaskar [1 ]
Dai, Junbiao [1 ]
Miao, Yungen [2 ]
Gao, Guanjun [1 ]
机构
[1] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China
[2] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China
来源
PLOS ONE | 2014年 / 9卷 / 07期
基金
中国国家自然科学基金;
关键词
GUIDED CAS9 NUCLEASE; CAENORHABDITIS-ELEGANS; TARGETED MUTAGENESIS; HUMAN-CELLS; URIC-ACID; RNA; DROSOPHILA; SYSTEMS; GENES; TRANSFORMATION;
D O I
10.1371/journal.pone.0101210
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We report the establishment of an efficient and heritable gene mutagenesis method in the silkworm Bombyx mori using modified type II clustered regularly interspaced short palindromic repeats (CRISPR) with an associated protein (Cas9) system. Using four loci Bm-ok, BmKMO, BmTH, and Bmtan as candidates, we proved that genome alterations at specific sites could be induced by direct microinjection of specific guide RNA and Cas9-mRNA into silkworm embryos. Mutation frequencies of 16.7-35.0% were observed in the injected generation, and DNA fragments deletions were also noted. Bm-ok mosaic mutants were used to test for mutant heritability due to the easily determined translucent epidermal phenotype of Bm-ok-disrupted cells. Two crossing strategies were used. In the first, injected Bm-ok moths were crossed with wild-type moths, and a 28.6% frequency of germline mutation transmission was observed. In the second strategy, two Bm-ok mosaic mutant moths were crossed with each other, and 93.6% of the offsprings appeared mutations in both alleles of Bm-ok gene (compound heterozygous). In summary, the CRISPR/Cas9 system can act as a highly specific and heritable gene-editing tool in Bombyx mori.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Translating CRISPR/Cas9 genome editing into therapeutics
    Barnes, T. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A140 - A141
  • [32] Efficient Mitochondrial Genome Editing by CRISPR/Cas9
    Jo, Areum
    Ham, Sangwoo
    Lee, Gum Hwa
    Lee, Yun-Il
    Kim, SangSeong
    Lee, Yun-Song
    Shin, Joo-Ho
    Lee, Yunjong
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [33] CRISPR/Cas9: Transcending the Reality of Genome Editing
    Chira, Sergiu
    Gulei, Diana
    Hajitou, Amin
    Zimta, Alina-Andreea
    Cordelier, Pierre
    Berindan-Neagoe, Ioana
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2017, 7 : 211 - 222
  • [34] Genome editing with AAV using CRISPR/Cas9
    Wilson, J. M.
    HUMAN GENE THERAPY, 2016, 27 (11) : A18 - A18
  • [35] Delivery of CRISPR/Cas9 for therapeutic genome editing
    Xu, Xiaojie
    Wan, Tao
    Xin, Huhu
    Li, Da
    Pan, Hongming
    Wu, Jun
    Ping, Yuan
    JOURNAL OF GENE MEDICINE, 2019, 21 (07):
  • [36] CRISPR/Cas9 editing of the genome for cancer modeling
    Guernet, Alexis
    Grumolato, Luca
    METHODS, 2017, 121 : 130 - 137
  • [37] Enhancements of the CRISPR-Cas System in the Silkworm Bombyx mori
    Tsubota, Takuya
    Takasu, Yoko
    Yonemura, Naoyuki
    Sezutsu, Hideki
    CRISPR JOURNAL, 2025,
  • [38] Efficient Editing of an Adenoviral Vector Genome with CRISPR/Cas9
    Li, Qiang
    Wang, Hui
    Gong, Chen-yu
    Chen, Zhao
    Yang, Jia-xing
    Shao, Hong-wei
    Zhang, Wen-feng
    INDIAN JOURNAL OF MICROBIOLOGY, 2021, 61 (01) : 91 - 95
  • [39] CRISPR/Cas9 genome editing through in planta transformation
    Zlobin, Nikolay E.
    Lebedeva, Marina V.
    Taranov, Vasiliy V.
    CRITICAL REVIEWS IN BIOTECHNOLOGY, 2020, 40 (02) : 153 - 168
  • [40] CRISPR/Cas9 for genome editing: progress, implications and challenges
    Zhang, Feng
    Wen, Yan
    Guo, Xiong
    HUMAN MOLECULAR GENETICS, 2014, 23 : R40 - R46